221 related articles for article (PubMed ID: 32571875)
1. PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
Kozlov G; Funato Y; Chen YS; Zhang Z; Illes K; Miki H; Gehring K
J Biol Chem; 2020 Aug; 295(33):11682-11692. PubMed ID: 32571875
[TBL] [Abstract][Full Text] [Related]
2. PRL3 phosphatase active site is required for binding the putative magnesium transporter CNNM3.
Zhang H; Kozlov G; Li X; Wu H; Gulerez I; Gehring K
Sci Rep; 2017 Mar; 7(1):48. PubMed ID: 28246390
[TBL] [Abstract][Full Text] [Related]
3. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
Gehring K; Kozlov G; Yang M; Fakih R
J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
[TBL] [Abstract][Full Text] [Related]
4. Phosphocysteine in the PRL-CNNM pathway mediates magnesium homeostasis.
Gulerez I; Funato Y; Wu H; Yang M; Kozlov G; Miki H; Gehring K
EMBO Rep; 2016 Dec; 17(12):1890-1900. PubMed ID: 27856537
[TBL] [Abstract][Full Text] [Related]
5. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
Fakih R; Goldstein RH; Kozlov G; Gehring K
J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
[TBL] [Abstract][Full Text] [Related]
7. The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis.
Hardy S; Uetani N; Wong N; Kostantin E; Labbé DP; Bégin LR; Mes-Masson A; Miranda-Saavedra D; Tremblay ML
Oncogene; 2015 Feb; 34(8):986-95. PubMed ID: 24632616
[TBL] [Abstract][Full Text] [Related]
8. PRL-3: a metastasis-associated phosphatase in search of a function.
Bessette DC; Wong PC; Pallen CJ
Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
[TBL] [Abstract][Full Text] [Related]
11. PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo.
Qian F; Li YP; Sheng X; Zhang ZC; Song R; Dong W; Cao SX; Hua ZC; Xu Q
Mol Med; 2007; 13(3-4):151-9. PubMed ID: 17592549
[TBL] [Abstract][Full Text] [Related]
12. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
[TBL] [Abstract][Full Text] [Related]
13. Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.
Walls CD; Iliuk A; Bai Y; Wang M; Tao WA; Zhang ZY
Mol Cell Proteomics; 2013 Dec; 12(12):3759-77. PubMed ID: 24030100
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL).
Ishii T; Funato Y; Miki H
J Biol Chem; 2013 Mar; 288(10):7263-70. PubMed ID: 23362275
[TBL] [Abstract][Full Text] [Related]
15. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic analysis of mouse melanoma cell line B16, a metastatic descendant B16F10, and B16 overexpressing the metastasis-associated tyrosine phosphatase PRL-3.
Kim SH; Kim Y; Kim M; Kim DS; Lee SC; Chi SW; Lee DH; Park SG; Park BC; Bae KH; Kang S
Oncol Res; 2009; 17(11-12):601-12. PubMed ID: 19806791
[TBL] [Abstract][Full Text] [Related]
17. Targeting PRL phosphatases in hematological malignancies.
Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the PRL phosphatases.
Rios P; Li X; Köhn M
FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
[TBL] [Abstract][Full Text] [Related]
19. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
[TBL] [Abstract][Full Text] [Related]
20. PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
Johansson JA; Marie KL; Lu Y; Brombin A; Santoriello C; Zeng Z; Zich J; Gautier P; von Kriegsheim A; Brunsdon H; Wheeler AP; Dreger M; Houston DR; Dooley CM; Sims AH; Busch-Nentwich EM; Zon LI; Illingworth RS; Patton EE
Dev Cell; 2020 Aug; 54(3):317-332.e9. PubMed ID: 32652076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]